We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Eterna Therapeutics Inc | NASDAQ:ERNA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.03 | -1.48% | 2.00 | 2.00 | 2.07 | 2.0661 | 1.94 | 2.02 | 11,797 | 19:09:23 |
|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
||
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading symbol
|
Name of each exchange on which registered
|
||
|
|
|
Item 3.01 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
|
Eterna Therapeutics Inc.
|
||
Dated: January 19, 2024
|
By:
|
/s/ Sanjeev Luther
|
President and Chief Executive Officer
|
Document and Entity Information |
Jan. 17, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jan. 17, 2024 |
Entity File Number | 001-11460 |
Entity Registrant Name | Eterna Therapeutics Inc. |
Entity Central Index Key | 0000748592 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 31-1103425 |
Entity Address, Address Line One | 1035 Cambridge Street |
Entity Address, Address Line Two | Suite 18A |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02141 |
City Area Code | 212 |
Local Phone Number | 582-1199 |
Title of 12(b) Security | Common Stock, par value $0.005 per share |
Trading Symbol | ERNA |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
1 Year Eterna Therapeutics Chart |
1 Month Eterna Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions